abstract |
The application describes compounds of formula (IA) or (IB) based on pharmaceutical compositions that are suitable for modulating G protein-coupled receptor 120 (GPR120), and methods for using such compounds to treat, alleviate or prevent a condition caused by a pathological or unregulated GPR120 receptor. |